FDA approves subcutaneous version of Bristol Myers’ Opdivonews2024-12-27T16:59:44+00:00December 27th, 2024|Endpoints News|
Federal appeals court says Teva must delist Orange Book inhaler patentsnews2024-12-23T19:08:01+00:00December 23rd, 2024|Endpoints News|
Drugmakers sue government over 340B discounts to STD clinicsnews2024-12-23T18:41:47+00:00December 23rd, 2024|Endpoints News|
Viatris’ India-based manufacturing site blocked from shipping 11 generic drugs to USnews2024-12-23T18:06:05+00:00December 23rd, 2024|Endpoints News|
Sumitomo’s overactive bladder drug adds another indicationnews2024-12-23T17:39:13+00:00December 23rd, 2024|Endpoints News|
PDUFAs for Tonix and Nuvation; Sanofi vaccine partnership; RAPT allergy dealnews2024-12-23T14:56:45+00:00December 23rd, 2024|Endpoints News|
FDA approves Lilly weight loss drug Zepbound for sleep apneanews2024-12-23T14:27:20+00:00December 23rd, 2024|Endpoints News|
Novo Nordisk’s once-daily hemophilia drug Alhemo is approvednews2024-12-23T12:52:19+00:00December 23rd, 2024|Endpoints News|
Vertex gets ‘vanza triple’ approval and Trikafta expansionnews2024-12-23T02:56:01+00:00December 23rd, 2024|Endpoints News|
PBM changes unlikely to join spending bill as shutdown loomsnews2024-12-20T20:17:15+00:00December 20th, 2024|Endpoints News|
